Featured Press Releases

MalarVx licenses HDT Bio

MalarVx licenses HDT Bio's repRNA/LION™ technology to develop a groundbreaking malaria vaccine

Novotech receives new investment from GIC, Temasek, and existing investor TPG to accelerate global growth

Novotech receives new investment from GIC, Temasek, and existing investor TPG to accelerate global growth

  • 12 Apr 2025

Novotech, a globally recognized full-service biotech specialist clinical research organization...

ChromaDex expands its pharmaceutical-grade Niagen® IV and injection offerings to more leading wellness clinics.

ChromaDex expands its pharmaceutical-grade Niagen® IV and injection offerings to more leading wellness clinics.

FDA Approves Arrowhead Pharmaceuticals’ REDEMPLO® (plozasiran) for Reducing Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS).

FDA Approves Arrowhead Pharmaceuticals’ REDEMPLO® (plozasiran) for Reducing Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS).

Centinel Spine

Centinel Spine's Match-the-Disc™ prodisc® Cervical Total Disc Replacement System has completed over 10,000 procedures in the U.S

VASTHERA Receives U.S. FDA Clearance to Begin Phase 1 Clinical Trial of Pulmonary Arterial Hypertension Drug Candidate, VTB-10

VASTHERA Receives U.S. FDA Clearance to Begin Phase 1 Clinical Trial of Pulmonary Arterial Hypertension Drug Candidate, VTB-10

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

  • NeurOptics
  • 13 May 2026
SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

  • SuanNutra USA
  • 13 May 2026
MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

  • CVS Health
  • 13 May 2026
Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

  • Avid Bioservices
  • 12 May 2026
BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

  • Partner Therapeutics, Inc.
  • 12 May 2026
Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

  • Miach Orthopaedics, Inc.
  • 11 May 2026
The Digital Pharma Advances Conference 2026

Most Popular
May   2026
M T W T F S S
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.